Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Abortion Drugs

Abortion Drugs

82 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
82 results
Abortion Drugs

FDA Decision to Relax Chemical Abortion Rule Ignores the Science, Neglects Women, Places Them in Danger

"Our review of all the Adverse Events from mifepristone as an abortion drug revealed serious concerns about hemorrhage, infections, and…

charlotte-lozier-institute Charlotte Lozier Institute
April 13, 2021
Please login to bookmark Close
featured-image
Abortion Drugs

Slight Increase in Abortion Rate Largely Due to Surge in Chemical Abortion Nationwide

Today the U.S. Centers for Disease Control (CDC) released new data on abortion rates in 2018. The report generally comports…

Abortion Drugs

Medical and Social Risks Associated with Unmitigated Distribution of Mifepristone: A Primer

Chemical abortions, or “medication” abortions, have become a more prevalent method of abortion in recent years in the United States.…

featured-image
Abortion Drugs

FDA’s Race to Defend Women From Dangerous Drugs

Abortion advocates—seeking to exploit the COVID-19 crisis to advance unfettered access to abortion-inducing drugs—found a friend in federal court.  In…

featured-image
Abortion Drugs

The “No-Test Medication Abortion” Protocol: Experimenting with Women’s Health

A trend of mounting concern is occurring in abortion provision.  When elective induced abortion was legalized in the United States…

featured-image
Abortion Drugs

#AbortionChangesYou: A Case Study to Understand the Communicative Tensions in Women’s Medication Abortion Narratives

Our study is one of the first to analyze women’s narratives after having had a medication abortion. Using relational dialectics…

featured-image
Abortion Drugs

CLI Responds to Halting of Abortion Pill Trial

“Pro-abortion researchers would rather continue to mislead women about the real risks of the abortion pill regimen Mifeprex than protect them…

featured-image
Abortion Drugs

News Release: Abortion Activist Sues FDA over Regulation of Dangerous Drugs 

Today Charlotte Lozier Institute released the following response to a lawsuit seeking to stop U.S. Food and Drug Administration enforcement…

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image